Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ITI
Rockville, Maryland, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Immunomic Therapeutics is a clinical-stage biotech company developing nucleic acid-based immunotherapies using its proprietary UNITE® platform, which leverages lysosomal targeting to enhance immune responses to cancer and allergy targets. The company’s lead programs are in Phase 2 for glioblastoma (GBM), with additional programs in Phase 1 targeting GBM, Merkel cell carcinoma, and exploring broader oncology and allergy applications. Partnerships include Astellas Pharma for allergy programs and academic collaborations with leading cancer centers.
- Therapeutic areas
- OncologyImmunology
- Modalities
- mRNA-based drugsDNA vaccineDendritic cell therapyVaccine
- Industry
- Biotech
02
Partnerships
Astellas Pharma (allergy)Fred Hutchinson Cancer Research InstituteJohns Hopkins University of MedicineDuke UniversityUniversity of FloridaDana-Farber Cancer InstituteIchor Medical Systems (electroporation delivery for ITI-1001)
Beyond the preview
Go deeper on ITI.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ITI.